Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2011, Article ID 463704, 11 pages
http://dx.doi.org/10.1155/2011/463704
Review Article

Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings

1Medical Research Council (UK) Laboratories, Atlantic Road, P.O. Box 273, Fajara, Gambia
2Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK
3MRC/UCL Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, UK

Received 27 May 2010; Accepted 12 December 2010

Academic Editor: Ann Duerr

Copyright © 2011 Kevin Peterson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [29 citations]

The following is the list of published articles that have cited the current article.

  • Yunfeng Tie, Yuan-Fang Wang, Peter I. Boross, Ting-Yi Chiu, Arun K. Ghosh, Jozsef Tozser, John M. Louis, Robert W. Harrison, and Irene T. Weber, “Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors,” Protein Science, vol. 21, no. 3, pp. 339–350, 2012. View at Publisher · View at Google Scholar
  • Kevin Peterson, Jean Ruelle, Marc Vekemans, Frederick P. Siegal, Jane R. Deayton, and Robert Colebunders, “The role of raltegravir in the treatment of HIV-2 infections: evidence from a case series,” Antiviral Therapy, vol. 17, no. 6, pp. 1097–1100, 2012. View at Publisher · View at Google Scholar
  • Pedro Borrego, Rita Calado, Jose M. Marcelino, Ines Bartolo, Cheila Rocha, Patricia Cavaco-Silva, Manuela Doroana, Francisco Antunes, Fernando Maltez, Umbelina Caixas, Helena Barroso, and Nuno Taveira, “Baseline susceptibility of primary HIV-2 to entry inhibitors,” Antiviral Therapy, vol. 17, no. 3, pp. 565–570, 2012. View at Publisher · View at Google Scholar
  • Kevin Peterson, and Sarah Rowland-Jones, “Novel agents for the treatment of HIV-2 infection,” Antiviral Therapy, vol. 17, no. 3, pp. 435–438, 2012. View at Publisher · View at Google Scholar
  • Eirini Moysi, Thushan de Silva, and Sarah Rowland-Jones, “Immune Mechanisms of Viral Control in HIV-2 Infection,” Models of Protection Against HIV/SIV, pp. 293–315, 2012. View at Publisher · View at Google Scholar
  • Didier K. Ekouevi, Serge P. Eholie, Geoffrey S. Gottlieb, François Dabis, Eric Balestre, Patrick A. Coffie, Daouda Minta, Eugene Messou, Adrien Sawadogo, Albert Minga, Papa Salif Sow, and Emmanuel Bissagnene, “Characteristics of HIV-2 and HIV-1/HIV-2 dually seropositive adults in West Africa presenting for care and antiretroviral therapy: The IeDEA-West Africa HIV-2 cohort study,” PLoS ONE, vol. 8, no. 6, 2013. View at Publisher · View at Google Scholar
  • Kristen Andreatta, Michael D. Miller, and Kirsten L. White, “HIV-2 Antiviral Potency and Selection of Drug Resistance Mutations by the Integrase Strand Transfer Inhibitor Elvitegravir and NRTIs Emtricitabine and Tenofovir In Vitro,” Jaids-Journal Of Acquired Immune Deficiency Syndromes, vol. 62, no. 4, pp. 367–374, 2013. View at Publisher · View at Google Scholar
  • Samuel Nyamweya, Andrea Hegedus, Assan Jaye, Sarah Rowland-Jones, Katie L. Flanagan, and Derek C. Macallan, “Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis,” Reviews in Medical Virology, 2013. View at Publisher · View at Google Scholar
  • Georgina Njideka Odaibo, and David Olufemi Olaleye, “Laboratory Profile of HIV-2 and Dual HIV-1/HIV-2 Associated Acquired Immunodeficiency Syndrome in Nigeria,” World Journal of AIDS, vol. 03, no. 03, pp. 192–196, 2013. View at Publisher · View at Google Scholar
  • Yue Zheng, Christine Lambert, Vic Arendt, and Carole Seguin-Devaux, “Virological and immunological outcomes of elvitegravir-based regimen in a treatment-naive HIV-2-infected patient,” Aids, vol. 28, no. 15, pp. 2329–2331, 2014. View at Publisher · View at Google Scholar
  • Didier K. Ekouevi, Boris K. Tchounga, Patrick A. Coffie, Joseph Tegbe, Alexandra M. Anderson, Geoffrey S. Gottlieb, Marco Vitoria, Francois Dabis, and Serge P. Eholie, “Antiretroviral therapy response among HIV-2 infected patients: a systematic review,” Bmc Infectious Diseases, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Natacha Herssens, Greet Beelaert, and Katrien Fransen, “Discriminatory Capacity Between HIV-1 and HIV-2 of the New Rapid Confirmation Assay Geenius,” Journal of Virological Methods, 2014. View at Publisher · View at Google Scholar
  • Linda L. Jagodzinski, Ying Liu, Holly R. Hack, Catherine Kibirige, Sheila A. Peel, and Mark M. Manak, “Discrepant Amplification Results during the Development of an Assay Leads to Reclassification of Two AIDS Reagent Repository HIV-2 Isolates as HIV-1,” Plos One, vol. 9, no. 5, 2014. View at Publisher · View at Google Scholar
  • Andrew F. Auld, Kunomboa A. Ekra, Ray W. Shiraishi, Moise Z. Tuho, Joseph S. Kouakou, Fayama Mohamed, Virginie Ettiegne-Traore, Jennifer Sabatier, Joseph Essombo, Georgette Adjorlolo-Johnson, Richard Marlink, and Tedd V. Ellerbrock, “Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Cote d'Ivoire's National Antiretroviral Therapy Program,” Plos One, vol. 9, no. 5, 2014. View at Publisher · View at Google Scholar
  • Luis Menendez-Arias, and Mar Alvarez, “Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection,” Antiviral Research, vol. 102, pp. 70–86, 2014. View at Publisher · View at Google Scholar
  • M. A. Prasolova, M. K. Ivanov, N. M. Gashnikova, E. S. Netesova, and G. M. Dymshits, “A Single-tube real-time RT-PCR assay for RNA detection and quantification of genetically diverse HIV including rare HIV-1 non-m groups and HIV-2,” Molecular Genetics Microbiology And Virology, vol. 29, no. 4, pp. 179–185, 2014. View at Publisher · View at Google Scholar
  • Bo Langhoff Honge, Magnus Petur Bjarnason Obinah, Sanne Jespersen, Candida Medina, David da Silva Te, Zacarias Jose da Silva, Lars Ostergaard, Alex Lund Laursen, Christian Wejse, and Christian Erikstrup, “Performance of 3 Rapid Tests for Discrimination Between HIV-1 and HIV-2 in Guinea-Bissau, West Africa,” Jaids-Journal of Acquired Immune Deficiency Syndromes, vol. 65, no. 1, pp. 87–90, 2014. View at Publisher · View at Google Scholar
  • Mansour Farahani, Anusha Vable, Refeletswe Lebelonyane, Khumo Seipone, Marina Anderson, Ava Avalos, Tim Chadborn, Hailu Tilahun, Danae Roumis, Themba Moeti, Godfrey Musuka, Lesego Busang, Tendani Gaolathe, Kolaatamo C. S. Malefho, and Richard Marlink, “Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis,” Lancet Global Health, vol. 2, no. 1, pp. E44–E50, 2014. View at Publisher · View at Google Scholar
  • Robin Wood, “Clinical Features and Management of HIV/AIDS,” Manson's Tropical Infectious Diseases, pp. 79–96.e6, 2014. View at Publisher · View at Google Scholar
  • Didier K. Ekouevl, Veronique Avettand-Fenoel, Boris K. Tchounga, Patrick A. Coffie, Adrien Sawadogo, Daouda Minta, Albert Minga, Serge P. Eholie, Jean-Christophe Plantier, Florence Damond, Francois Dabis, and Christine Rouzioux, “Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration,” Plos One, vol. 10, no. 6, 2015. View at Publisher · View at Google Scholar
  • Robert A. Smith, Dana N. Raugi, Vincent H. Wu, Sally S. Leong, Kate M. Parker, Mariah K. Oakes, Papa Salif Sow, Selly Ba, Moussa Seydi, and Geoffrey S. Gottlieb, “The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1,” Antimicrobial Agents And Chemotherapy, vol. 59, no. 12, pp. 7437–7446, 2015. View at Publisher · View at Google Scholar
  • Mohamed Mahdi, Zsófia Szojka, János Mótyán, and József Tőzsér, “Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System,” Viruses, vol. 7, no. 12, pp. 6152–6162, 2015. View at Publisher · View at Google Scholar
  • Eric Balestre, Didier Koumavi Ekouevi, Boris Tchounga, Serge Paul Eholie, Eugene Messou, Adrien Sawadogo, Rodolphe Thiebaut, Margaret T. May, Jonathan Ac Sterne, and Francois Dabis, “Immunologic response in treatment-naive HIV-2-infected patients: the IeDEA West Africa cohort,” Journal Of The International Aids Society, vol. 19, 2016. View at Publisher · View at Google Scholar
  • Stephanie Rebensburg, Markus Helfer, Martha Schneider, Herwig Koppensteiner, Josef Eberle, Michael Schindler, Lutz Gürtler, and Ruth Brack-Werner, “Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins,” Scientific Reports, vol. 6, pp. 20394, 2016. View at Publisher · View at Google Scholar
  • Mar Álvarez, Alba Sebastián-Martín, Luis Menéndez-Arias, and Guillermo García-Marquina, “Fidelity of classwide-resistant HIV-2 reverse transcriptase and differential contribution of K65R to the accuracy of HIV-1 and HIV-2 reverse transcriptases,” Scientific Reports, vol. 7, 2017. View at Publisher · View at Google Scholar
  • Amivi Amenyah- Ehlan, Mounerou Salou, Malewe Kolou, Komlan Ali- Edje, Tufa Nyasenu, Sika Dossim, Alassane Ouro- Medeli, Mensah Douffan, Anoumou Dagnra, and Mireille Prince- David, “Trends in HIV-2 Seroprevalence at the National Reference Center of HIV from 2005 to 2014 in Lome, Togo,” World Journal of AIDS, vol. 07, no. 04, pp. 239–246, 2017. View at Publisher · View at Google Scholar
  • Yalong Cong, Yuchen Li, Kun Jin, Susu Zhong, John Z. H. Zhang, Hao Li, and Lili Duan, “Exploring the Reasons for Decrease in Binding Affinity of HIV-2 Against HIV-1 Protease Complex Using Interaction Entropy Under Polarized Force Field,” Frontiers in Chemistry, vol. 6, 2018. View at Publisher · View at Google Scholar
  • Lin Zhang, Li-jun Zha, Hong-zhou Lu, Zheng Zhu, Yan Hu, Hui-wen Li, Mei-juan Bao, and Xue-hong Hou, “The implementation and evaluation of HIV symptom management guidelines: A preliminary study in China,” International Journal of Nursing Sciences, 2018. View at Publisher · View at Google Scholar
  • S. Salwe, V. Padwal, V. Nagar, P. Patil, and V. Patel, “T cell functionality in HIV‐1, HIV‐2 and dually infected individuals: correlates of disease progression and immune restoration,” Clinical & Experimental Immunology, 2019. View at Publisher · View at Google Scholar